Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan

Infection Control and Hospital Epidemiology

Volumn 25, Issue 7, 2004, Pages 591-594

  Hatakeyama, Shuji ^a   Moriya, Kyoji ^a   Itoyama, Satoru ^a   Nukui, Yoko ^a   Uchida, Miho ^a   Shintani, Yoshizumi ^a   Morisawa, Yuji ^a   Kimura, Satoshi ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; RUBELLA ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; CHICKENPOX; COST CONTROL; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEASLES; MEASLES VACCINATION; MUMPS; PREDICTION; RUBELLA; SERODIAGNOSIS; UNIVERSITY HOSPITAL; VACCINATION;

ADULT; AGED; ANTIBODIES, VIRAL; CHICKENPOX; DISEASE OUTBREAKS; ENVIRONMENTAL MONITORING; FEMALE; HEALTH PERSONNEL; HUMANS; JAPAN; MALE; MASS SCREENING; MEASLES; MIDDLE AGED; MUMPS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RUBELLA; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS;

EID: 3242711562     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502444     Document Type: Article

References (21)

1. Nakatani H, Sano T, Iuchi T. Development of vaccination policy in Japan: current issues and policy directions. Jpn J Infect Dis 2002;55:101-111.
2. Infectious Diseases Surveillance Center of the National Institute of Infectious Diseases. Measles, Japan 1999-2001 [in Japanese]. Infectious Agents Surveillance Report 2001;22:273-274. Available at idsc.nih.go.jp/ iasr/iasr-gel.html. Accessed June 16, 2003.
3. Infectious Diseases Surveillance Center of the National Institute of Infectious Diseases. Rubella vaccine coverage in Japan [in Japanese]. Infectious Agents Surveillance Report 2003;24:55-57.
4. Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 1991;10:209-213.
5. Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J 1991;10:204-209.
6. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 1995;346:701-702.
7. Nakayama T, Zhou J, Fujino M. Current status of measles in Japan. J Infect Chemother 2003;9:1-7.
8. Centers for Disease Control and Prevention. Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997;46(RR-18):1-42.
9. Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998;47(RR-8):1-57.
10. Centers for Disease Control and Prevention. Prevention of varicella: update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45(RR-11):1-36.
11. Neumann PW, Weber JM, Jessamine AG, O'Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol 1985;22:296-298.
12. Skendzel LP, Edson DC. Evaluation of enzyme immunosorbent rubella assays. Arch Pathol Lab Med 1985;109:391-393.
13. Popow-Kraupp T. Enzyme-linked immunosorbent assay (ELISA) for mumps virus antibodies. J Med Virol 1981;8:79-88.
14. World Health Organization. Measles: progress towards global control and regional elimination, 1998-1999. Wkly Epidemiol Rec 1999;74:429-434.
15. Hersh BS, Tambini G, Nogueira AC, Carrasco P, de Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000;355:1943-1948.
16. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months: United States, 2001. MMWR 2002;51:664-666.
17. Fedeli U, Zanetti C, Saia B. Susceptibility of healthcare workers to measles, mumps, rubella and varicella. J Hosp Infect 2002;51:133-135.
18. Ferson MJ, Robertson PW, Whybin LR. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps. Med J Aust 1994;160:478-482.
19. Infectious Diseases Surveillance Center of the National Institute of Infectious Diseases. Measles antibody prevalence and vaccine coverage in Japan, 2000: National Epidemiological Surveillance of Vaccine-Preventable Diseases [in Japanese]. Infectious Agents Surveillance Report 2001;22:275-277.
20. Subbarao EK, Amin S, Kumar ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991;163:876-878.
21. Sellick JA Jr, Longbine D, Schifeling R, Mylotte JM. Screening hospital employees for measles immunity is more cost effective than blind immunization. Ann Intern Med 1992;116:982-984.